Antioxidative therapy and vascular diseases;Antioxidative therapie bei gefȧß- und nierenerkrankungen

Medizinische Klinik

Volumn 97, Issue 3, 2002, Pages 144-151

  Tepel, Martin ^a   Van der Giet, Markus ^a   Zidek, Walter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antioxidants; Cardiovascular mortality; Renal failure

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CONTRAST MEDIUM; DRUG; THIOL; TOCOPHEROL; VITAMIN; PLACEBO; REACTIVE OXYGEN METABOLITE;

CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORALITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; VASCULAR DISEASE; ADULT; ANIMAL; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; FEMALE; LIPID PEROXIDATION; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK; RISK FACTOR; SMOKING;

ADULT; ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; CONTROLLED CLINICAL TRIALS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; RISK; RISK FACTORS; SMOKING; TOCOPHEROLS; VITAMINS;

EID: 18144432783     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1138-8     Document Type: Review

References (79)

1. Effect of superoxide dismutase treatment on gentamicin nephrotoxicity in rats
2. Oxidant mechanisms in toxic acute renal failure
3. Protein oxidation in aging, disease and oxidative stress
4. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients
5. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia
6. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): A randomised placebo-controlled trial
7. Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: A brief overview
8. Age-related progressive renal fibrosis in rats and ist prevention with ACE inhibitors and taurine
9. Biochemistry and pathology of radical-mediated protein oxidation
10. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells
11. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stneosed canine coronary arteries
12. Antioxidants and atherosclerotic heart disease
13. N-acetylcysteine ameliorates ischemic renal failure
14. Treatment of hypertension with ascorbic acid
15. Comparison of antioxidant potentials of red wine, white wine, grape juice and alcohol
16. Vitamin C intake and mortality among a sample of the United States population
17. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats
18. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons
19. Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to undergo lipid peroxidation
20. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
21. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
22. Hepatorenal syndrome
23. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction. Results of the GISSI-prevenzione trial
24. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muslce cells
25. NAD(P)H oxidase. Role in cardiovascular biology and disease
26. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
27. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome
28. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induced p27kip1. Role in angiotensin 11-mediated hypertrophy of proximal tubular cells
29. The involvement of oxidative stress in the progression of renal injury
30. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
31. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine
32. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
33. Redox regulation of cellular signalling
34. Acute renal failure from intoxication by Cortinarius orellanus: Recovery using antioxidant therapy and steroids
35. Antioxidants for hypertension
36. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam Study
37. Carvedilol: A beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats
38. Oxidative stress as a regulator of gene expression in the vasculature
39. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
40. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats
41. Noradrenergic vascular hyper-responsiveness in human hypertension is dependent on oxygen free radical impairment of nitric oxide activity
42. Morbidity, and mortality on maintenance hemodialysis
43. Emerging approaches in preventing cardiovascular disease
44. Role of nitric oxide as mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
45. Relevance of oxidative and carbonyl stress to long-term uremic complications
46. Hemodialysis impairs endothelial function via oxidative stress. Effects of vitamin E-coated dialyzer
47. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients
48. Contrast nephropathy
49. Effect of probucol in a murine model of slowly progressive polycystic kidney disease
50. Improvement in the outcome of rejection with pentoxifylline in renal transplantation: A randomized controlled trial
51. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts
52. Oxidants an dantioxidants in atherogenesis: An appraisal
53. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
54. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
55. Vitamin E consumption and the risk of coronary heart disease in men
56. Mitogen-activated protein kinase pathways
57. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis
58. Cisplatin induces N-acetylcystein suppressible F2-isoprostane production and injury in renal tubular epithelial cells
59. Effects of saline, mannitol, an furosemide on acute decreases in renal function induced by radiocontrast agents
60. Vitamin E consumption and the risk of coronary disease in women
61. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
62. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study
63. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats
64. Increased intracellular reactive oxygen species in patients with endstage chronic renal failure: Effect of hemodialysis
65. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
66. Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
67. Vitamin E supplementation and cardiovascular events in high-risk patients
68. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
69. p22phox is a critical component of superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II induced hypertrophy in vascular smooth muscle cells
70. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II role in vascular smooth muscle cell hypertrophy
71. The role of alcohol in the anti low density lipoprotein oxidation activity of red wine
72. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients
73. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
74. Cyclosporine nephrotoxicity: Attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo
75. The oxidation hypothesis of atherosclerosis
76. Interactions of oxidants with vascular signaling systems
77. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory, and metabolic predictors of atherosclerosis in ESRD
78. Arachidonic acid metabolites mediate angiotensin II induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells